ABSTRACT 16 The impact of type 1 diabetes (T1D) on muscle endurance and oxidative capacity is 17 currently unknown. Purpose: Measure muscle endurance and oxidative capacity of adults 18 with T1D compared to controls. Methods: A cross-sectional study design with a control 19 group was used. Subjects (19-37 years old) with T1D (n=17) and controls (n=17) were 20 assessed with hemoglobin A1c (HbA1c) and casual glucose. Muscle endurance was
INTRODUCTION 42
Type 1 diabetes (T1D) is a prevalent autoimmune disease resulting from specific 43 immune-mediated destruction of pancreatic beta cells, which is managed using multiple 44 daily injections of insulin or an insulin pump along with careful monitoring of blood 45 glucose levels (1). If unmanaged or poorly treated, this disease can have consequences on 46 all organ systems, especially cardiovascular and renal, due to impacts on macro-and 47 microvascular systems, including atherosclerosis, endothelial permeability, and thickening 48 of capillary walls (2). T1D is also associated with decreased mitochondrial oxygen 49 consumption and impaired oxidative phosphorylation efficiency (3). Declining heart health 50 in those with T1D could be a direct result of chronic deterioration of mitochondrial function 51 due to oxidative stress (4, 5). People with T1D also report elevated fatigue that may be due 52 to increased pain, sleep disturbances, depressive symptoms, or the physiological impacts 53 of their condition (6). In a previous study, mitochondrial DNA mutations were observed in 54 diabetic tissues potentially due to oxidative stress (7) . A loss of muscle mass and fiber 55 atrophy has been associated with T1D (8) as well as decreased muscle strength (9), but 56 previous studies have been unable to confirm a relationship between fatigue and glucose 57 control in people with T1D. Further evidence is needed to determine the onset and effects 58 of T1D on mitochondria function and implications for muscle endurance.
59
Neuromuscular electrical stimulation (NMES) is a technique that has been used in 60 combination with a tri-axial wireless accelerometer to determine skeletal muscle endurance 61 (10-12). NMES has also been used in various other forms of assessing fatigue including 62 handgrip fatigue (13) due to reduced variability associated with controlled, artificial 63 exercise. Near infrared spectroscopy (NIRS) has been used in previous studies as a non-64 invasive approach to measuring muscle oxygen consumption as a gauge of mitochondrial 65 capacity (14-16) as well as skeletal muscle blood flow (17). These technologies have been 66 applied to other populations, such as those with Friedrich's Ataxia (10), spinal cord injuries 67 (18), and peripheral vascular disease (19) .
68
The purpose of this study was to determine the association of T1D in young adults 69 with muscle endurance, mitochondrial capacity, and muscle reperfusion. We hypothesized 70 that T1D would be associated with reduced muscle endurance, a decreased rate of recovery 71 of muscle oxygen consumption, and a longer reperfusion rate. 
98
The endurance test (12) 127 15 seconds at 6 Hz as exercise to increase metabolic rate. Immediately following electrical 128 stimulation, a recovery test cuff protocol was performed: cuffs 1 through 10 were 5 seconds 129 on, 5 seconds off; cuffs 11 through 15 were 7 seconds on, 7 seconds off; cuffs 16 through 130 18 were 10 seconds on, 15 seconds off, and cuffs 19 and 20 were 10 seconds on, 20 seconds 131 off. The exercise and cuff protocol was repeated, and the two recovery tests were averaged 132 to measure the rate of recovery of muscle oxygen consumption, representing mitochondrial 133 oxidative capacity. Reproducibility of the mitochondrial capacity measurements has been 134 reported to be 12% in a previous study on the medial gastrocnemius muscle (22).
135
Data Analysis and Statistics: For the muscle endurance test, peak-to-peak 136 oscillations throughout stimulation was analyzed through Microsoft Excel and a MatlLab 137 analysis routine (12). The endurance index was calculated as the end acceleration of the 138 frequency period divided by the peak acceleration at the start of the stimulation period 139 multiplied by 100 percent to allow for comparison within and between groups. Oxymon 140 software was used to collect the data for the NIRS test, and the data was analyzed with a 141 Matlab analysis routine. Comparisons between groups were made with unpaired, two-142 tailed T tests using SPSS. Statistical significance was accepted with a p value <0.05.
143 Power estimates suggested that with a sample size of 17 per group and a population 144 variance of 20%; a difference between groups of 20% could be detected in the 145 mitochondrial rate constant with a power of 0.83.
146
147 RESULTS
148
The subject's physical characteristics are shown in Table 1 . Subjects with T1D had 149 higher casual glucose and HbA1c levels than controls, as expected. The subjects with T1D 150 also had slightly higher BMI and forearm adiposity measurements.
151
Muscle endurance, measured as the endurance index, was not different between 152 subjects with T1D and controls (p = 0.97, 0.12, 0.99 for 2, 4, and 6 Hz respectively) ( Figure   153 1A) . Muscle mitochondrial capacity measured as the recovery rate constant was also not 154 different between subjects with T1D and controls (p = 0.29) ( Figure 1B ). Muscle 155 reperfusion rate measured as the half time of recovery of oxygen saturation was not 156 different between subjects with T1D and controls (p = 0.88) ( Figure 1C ). There was no 157 relationship between HbA1c levels and Muscle endurance (6 Hz), mitochondrial capacity 158 or muscle reperfusion rate (r 2 values of 0.01, 0.10, and 0.01, respectively 
184
There were no differences muscle reperfusion rate between adults with T1D and 185 controls. We had hypothesized that T1D might damage blood vessels due to chronic 186 hyperglycemia and accompanying increased variability in blood glucose levels (32, 33).
187 Previous studies have shown that the rate of muscle reperfusion is an indicator of impaired 188 circulation (34, 35). While the subjects in our study were relatively young and had well-189 controlled blood sugar and HbA1c levels, previous studies have suggested vascular 190 abnormalities in similar populations (36, 37). Additional studies on older subjects with 191 T1D or in subjects with a history of poor glycemic control would are needed to better 192 understand the impact of T1D on muscle reperfusion rates.
193
In the present study, no correlations were found between well-controlled people 194 with T1D in the parameters tested regarding age, time since diagnosis, or HbA1c levels. 
202
The strengths of this study were that the tests performed were non-invasive and 
226
There were no differences seen between well-controlled adults with T1D and 227 similar controls in muscle endurance, mitochondrial capacity, or muscle reperfusion rate.
228 We had hypothesized that T1D might have reduced muscle endurance and mitochondrial 229 capacity due to suggestions of accelerated mitochondrial aging in this population. Poor 230 glycemic control is also associated with vascular pathology. We also did not see evidence 231 within our generally well controlled T1D subjects of relationships between muscle 232 endurance, muscle mitochondrial capacity, and muscle reperfusion rate and HbA1c levels.
233 It is possible that older or less well controlled subjects with T1D would have evidence of 234 impaired muscle function. More testing would need to be performed to understand the 235 effects of T1D muscle endurance, mitochondrial capacity, and microvascular function in 236 this subjects with T1D across ages and with different levels of glycemic control.
237
238 Acknowledgements
239
The results of this study are presented clearly, honestly, and without fabrication, 
